Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19)
Clinical trial NCT04352608 · COMPLETED
Trial details
- NCT number
- NCT04352608
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-16
- Primary completion
- 2020-07-10
- Enrollment
- 744
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.